v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating Expenses [Abstract]    
Research and development $ 1,266 $ 187
General and administrative 3,310 478
Total operating expenses 4,576 665
Loss from operations (4,576) (665)
Net loss and comprehensive loss $ (4,576) $ (665)
Net loss per share, basic $ (0.02) $ (0.01)
Net loss per share, diluted $ (0.02) $ (0.01)
Weighted average shares of common stock outstanding, basic 230,209,142 200,000,000
Weighted average shares of common stock outstanding, diluted 230,209,142 200,000,000